Morepen Laboratories Ltd Nine Monthly Results

Gross Sales

1,345.72

1,267.36

1,053.84

1,178.54

901.46

Excise Duty

0

0

0

0

0

Net Sales

1,345.72

1,267.36

1,053.84

1,178.54

901.46

Other Operating Income

0

0

0

0

0

Other Income

13.75

9.73

3.01

7.13

7.91

Total Income

1,359.47

1,277.09

1,056.86

1,185.67

909.36

Total Expenditure

1,214.53

1,157.11

989.87

1,060.55

813.34

PBIDT

144.95

119.97

66.98

125.13

96.02

Interest

3.67

2.91

1.42

-8.16

1.84

PBDT

141.28

117.06

65.57

133.29

94.18

Depreciation

11.88

23.85

20.95

20.76

23.3

Minority Interest Before NP

0

0

0

0

0

Tax

31.69

25.33

14.18

23.17

0.55

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

97.71

67.88

30.43

89.36

70.33

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

97.71

67.88

30.43

89.36

70.33

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

97.71

67.88

30.43

89.36

70.33

EPS (Unit Curr.)

1.85

1.33

0.6

1.99

1.56

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

109.58

102.23

102.23

89.96

89.96

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.77

9.46

6.35

10.61

10.65

PBDTM(%)

10.49

9.23

6.22

11.3

10.44

PATM(%)

7.26

5.35

2.88

7.58

7.8